The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells

被引：0
|
作者：
James W Welsh
Daruka Mahadevan
Ron Ellsworth
Laurence Cooke
David Bearss
Baldassarre Stea
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Departmentr of Radiation Oncology
[2] University of Arizona Cancer Center,Department of Medicine
[3] University of Arizona College of Medicine,Department of Radiation Oncology
[4] SuperGen Inc,undefined
[5] University of Arizona Cancer Center,undefined
来源：
Radiation Oncology | / 4卷
关键词：
Hepatocyte Growth Factor; Comet Assay; SF767 Cell; RAD51 Expression; Neutral Comet Assay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] KRC-327, a selective novel inhibitor of c-Met receptor tyrosine kinase with anticancer activity
    Park, Byung Hee
    Jung, Kyung Hee
    Yun, Sun-Mi
    Hong, Sang-Won
    Ryu, Jae Wook
    Jung, Heejung
    Ha, Jae Du
    Lee, Jongkook
    Hong, Soon-Sun
    CANCER LETTERS, 2013, 331 (02) : 158 - 166
  • [22] ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
    Munshi, Neru
    Jeay, Sebastien
    Li, Youzhi
    Chen, Chang-Rung
    France, Dennis S.
    Ashwell, Mark A.
    Hill, Jason
    Moussa, Magdi M.
    Leggett, David S.
    Li, Chiang J.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1544 - 1553
  • [23] Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2
    Navis, Anna C.
    Bourgonje, Annika
    Wesseling, Pieter
    Wright, Alan
    Hendriks, Wiljan
    Verrijp, Kiek
    van der Laak, Jeroen A. W. M.
    Heerschap, Arend
    Leenders, William P. J.
    PLOS ONE, 2013, 8 (03):
  • [24] The Receptor Tyrosine Kinase, AXL, Regulates c-MET in Epithelial Ovarian Cancer
    Fuh, Katherine C.
    Rankin, Erinn B.
    Longacre, Teri
    Kariolis, Mihalis
    Cochran, Jennifer
    Giaccia, Amato
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 93A - 94A
  • [25] Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
    Zhang, Yazhuo
    Xia, Mengfang
    Jin, Ke
    Wang, Shufei
    Wei, Hang
    Fan, Chunmei
    Wu, Yingfen
    Li, Xiaoling
    Li, Xiayu
    Li, Guiyuan
    Zeng, Zhaoyang
    Xiong, Wei
    MOLECULAR CANCER, 2018, 17
  • [26] Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
    Zhao, Shankun
    Wu, Weizhou
    Jiang, Hao
    Ma, Lei
    Pan, Chengyi
    Jin, Chong
    Mo, Jinggang
    Wang, Liezhi
    Wang, Kunpeng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
    Granito, Alessandro
    Guidetti, Elena
    Gramantieri, Laura
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 29 - 38
  • [28] Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
    Yazhuo Zhang
    Mengfang Xia
    Ke Jin
    Shufei Wang
    Hang Wei
    Chunmei Fan
    Yingfen Wu
    Xiaoling Li
    Xiayu Li
    Guiyuan Li
    Zhaoyang Zeng
    Wei Xiong
    Molecular Cancer, 17
  • [29] Oligomerization-induced differential dephosphorylation of c-Met receptor tyrosine kinase
    Sheth, PR
    Watowich, SJ
    BIOCHEMISTRY, 2005, 44 (33) : 10984 - 10993
  • [30] Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
    Birchmeier, C
    Gherardi, E
    TRENDS IN CELL BIOLOGY, 1998, 8 (10) : 404 - 410
12345